Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M132Revenue $M0.1Net Margin (%)--Altman Z-Score6.7
Enterprise Value $M102EPS $-0.1Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)--Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %-2.4Quick Ratio11.1Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-2.4Current Ratio11.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-22.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-29.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M180ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RNN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RNNKen Fisher 2014-09-30 Sold Out $0.662 - $0.875
($0.75)
$ 0.73-3%Sold Out0
RNNKen Fisher 2014-06-30 Buy $0.79 - $1.28
($0.95)
$ 0.73-23%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RNN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


RNN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Jeong Tae HeumCFO 2015-01-12Sell317,272$0.91-19.78 view
Ahn Chang HoDirector 2015-01-12Sell314,656$0.91-19.78 view
Ahn Chang HoDirector 2014-06-12Sell136,193$0.99-26.26 view
Jeong Tae HeumCFO 2013-09-09Sell71,139$0.4658.7 view
Kivel RichardDirector 2011-10-03Buy2,500$1.04-29.81 view
Brandt Peter C.Director 2011-09-09Buy125,000$1.17-37.61 view
Brandt Peter C.Director 2011-09-07Buy25,000$0.96-23.96 view
Ahn Chang HoChairman & CEO, 10% Owner 2011-05-18Buy1,008,078$1.31-44.27 view
Ahn Chang HoChairman & CEO, 10% Owner 2011-04-01Buy320,846$1.22-40.16 view
McIntosh David MDirector 2009-07-30Buy5,600$0.8-8.75 view

Press Releases about RNN :

    Quarterly/Annual Reports about RNN:

    News about RNN:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: RNN, IIG, FSC, GEO, DAN May 21 2011 
    Weekly CEO Buys Highlight: GBDC, EXL, RNN, KYN, CMTL Apr 09 2011 

    More From Other Websites
    5 Stocks Under $10 Ready to Spike Higher May 29 2015
    Strong Data on Rexahn's Non-Toxic Targeted Therapy Revealed at Top Cancer Meetings May 28 2015
    REXAHN PHARMACEUTICALS, INC. Financials May 15 2015
    Rexahn Announces Poster Presentations at the 2015 American Society of Clinical Oncology (ASCO)... May 13 2015
    Rexahn Announces Poster Presentations at the 2015 American Society of Clinical Oncology (ASCO)... May 13 2015
    Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update May 11 2015
    Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update May 11 2015
    10-Q for Rexahn Pharmaceuticals, Inc. May 10 2015
    REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 08 2015
    10-K for Rexahn Pharmaceuticals, Inc. May 04 2015
    New Data Show Rexahn's Supinoxin(TM) Decreases the Migration of Human Triple Negative Breast Cancer... Apr 21 2015
    New Data Show Rexahn's Supinoxin(TM) Decreases the Migration of Human Triple Negative Breast Cancer... Apr 21 2015
    Rexahn Identifies RX-3117 Biomarker & Presents Data at the 2015 American Association for Cancer... Apr 20 2015
    Rexahn Identifies RX-3117 Biomarker & Presents Data at the 2015 American Association for Cancer... Apr 20 2015
    Rexahn Pharmaceuticals to Present Data on RX-3117 and Supinoxin(TM) at the 2015 American Association... Apr 13 2015
    Print Apr 13 2015
    Rexahn Pharmaceuticals to Present Data on RX-3117 and Supinoxin(TM) at the 2015 American Association... Apr 13 2015
    UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic... Mar 20 2015
    Coverage initiated on Rexahn Pharmaceuticals by MLV & Co Mar 20 2015
    Rexahn Pharmaceuticals to Present at the 12th Annual BIO Asia International Conference in Tokyo,... Mar 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK